Trial Summary
What is the purpose of this trial?
The primary objective of the pilot study is to assess the feasibility of a definitive trial to determine the effect of arthroscopic capsuloligamentous repair (Bankart + Remplissage) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period.
Research Team
Moin Khan, MD
Principal Investigator
McMaster University
Eligibility Criteria
This trial is for adults aged 18-50 with a history of recurrent shoulder dislocation, specifically anterior dislocation confirmed by physical exam or imaging. Candidates should have mild glenoid bone loss and be able to give informed consent. It's not for those with previous shoulder surgery, epilepsy, other shoulder injuries like cuff tears, multidirectional instability, pregnancy, or certain connective tissue disorders.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Bankart + Remplissage Procedure (Procedure)
- Latarjet Procedure (Procedure)
Bankart + Remplissage Procedure is already approved in Canada for the following indications:
- Recurrent shoulder dislocations
- Anterior shoulder instability
Find a Clinic Near You
Who Is Running the Clinical Trial?
Moin Khan
Lead Sponsor
University of Michigan
Collaborator
Campus Bio-Medico University
Collaborator
OLVG
Collaborator
Hospital Universitario La Paz
Collaborator
Endeavor Health
Collaborator
Kingston Health Sciences Centre
Collaborator
University of Western Ontario, Canada
Collaborator
The Ottawa Hospital
Collaborator
Pan Am Clinic
Collaborator